article thumbnail

New Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The physician continues to accept insurance and government programs, as before. Members enjoy a closer doctor-patient relationship, convenient ways to connect with their cardiologist directly, even after hours, and relaxed, same-day/next-day appointments that never feel rushed. For more information, please visit www.ccpmd.com.

article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The physician continues to accept insurance and government programs, as before. Members enjoy a closer doctor-patient relationship, convenient ways to connect with their cardiologist directly, even after hours, and relaxed, same-day/next-day appointments that never feel rushed. For more information, please visit www.ccpmd.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Geriatric Medicine Board Meeting Summary | Spring 2025

ABIM

Upgrades to the ABIM website and Physician Portal for 2025, designed to make it easier for both physicians and the public to find information. Community Practice in ABIM Governance* Erica N. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations.

article thumbnail

Vanda-lay Litigation Industries, Inc.: Taking Stock of Vanda Pharmaceuticals, Inc.’s Big Bets on Petitioning and Litigation Against FDA and the Federal Government

FDA Law

District Court for the District of Columbia (“DDC”) against FDA alleging that the Agency’s structure of NDA review is unconstitutional (by our count the 31st Vanda litigation against FDA or another government entity in the last five years, including appeals). II, § 2, cl. In January 2024, the U.S. VANDA PHARMACEUTICALS, INC.

article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Upgrades to the ABIM website and Physician Portal for 2025 designed to make it easier for both physicians and the public to find information. Community Practice in ABIM Governance* Dr. Johnson led a discussion with the Rheumatology Board on community practice in rheumatology to create a more inclusive understanding of its role and scope.

article thumbnail

Podcast: AI, innovation, and value-based care in medicine

Permanente Medicine

Contributing to this challenge is the exponential growth of information, an expanding population of older adults, and office visit documentation. Information is coming at clinicians, whether they be doctors, nurses, pharmacists, faster than ever, and there is a transparency that exists around us.

article thumbnail

Price Limits, Affordability Boards, Penalties, Oh My: Minnesota Enacts Sweeping Drug Pricing Reforms

FDA Law

Under Minnesota’s Prescription Drug Price Transparency Act , manufacturers must submit detailed pricing information for any generic prescription drug with a WAC of at least $100 for a 30-day supply or shorter course of treatment for which it increased the WAC by 50% or greater over the previous 12-month period.